| Application no. and date | 05783732.0 (espacenet) (Federated) (European Patent Register), 20050809 | | Patent/reg. no. and date | DK/EP 1793855, 20181114 | | Publication date | 20070613 | | Priority no. and date | US 915214, 20040809, US 185907, 20050719 | | EP pub. no. and date |
EP 1793855 20070613 | | Effective date | | | Applicant/owner | The Regents of the University of California, 1111 Franklin Street, 12th Floor
Oakland, CA 94607, US,
Prothena Biosciences Limited, Adelphi Plaza
Upper George's Street
Dun Laoghaire Co., IE | | Applicant ref. no. | P66961DK01 | | Inventor | SCHENK, Dale, B., 1542 Los Altos Drive
Burlingame, CA 94010, US,
ROCKENSTEIN, Edward, 851 Fordham Avenue
Chula Vista, CA 91913, US,
MASLIAH, Eliezer, 4661 Corte Mar Corazon
San Diego, CA 92130, US,
BUTTINI, Manuel, J., 8 Admiral Drive, No. 131
Emeryville, CA 94608, US,
GAMES, Kate, Dora, 503 Alameda De Las Pulgas
Belmont, CA 94002, US,
CHILCOTE, Tamie, J., 187 Magellan Avenue
South San Francisco, CA 94116, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | C07K 16/18 (2006.01) | | Title | FOREBYGGELSE OG BEHANDLING AF SYNUKLEINOPATISK OG AMYLOIDOGENISK SYGDOM | | Int. application no. | US2005028166 | | Int. publication no. | WO2006020581 | | Related patent (certificate) | | | Status | Ændret DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
